Search by Drug Name or NDC

    NDC 50090-5611-00 NUVARING .015; .12 mg/d; mg/d Details

    NUVARING .015; .12 mg/d; mg/d

    NUVARING is a VAGINAL INSERT, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is ETHINYL ESTRADIOL; ETONOGESTREL.

    Product Information

    NDC 50090-5611
    Product ID 50090-5611_977cb584-edcb-49b9-9ab5-65074888bf94
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name NUVARING
    Proprietary Name Suffix n/a
    Non-Proprietary Name etonogestrel and ethinyl estradiol
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INSERT, EXTENDED RELEASE
    Route VAGINAL
    Active Ingredient Strength .015; .12
    Active Ingredient Units mg/d; mg/d
    Substance Name ETHINYL ESTRADIOL; ETONOGESTREL
    Labeler Name A-S Medication Solutions
    Pharmaceutical Class Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021187
    Listing Certified Through 2024-12-31

    Package

    NDC 50090-5611-00 (50090561100)

    NDC Package Code 50090-5611-0
    Billing NDC 50090561100
    Package 3 POUCH in 1 BOX (50090-5611-0) / 21 d in 1 POUCH
    Marketing Start Date 2021-08-12
    NDC Exclude Flag N
    Pricing Information N/A